DarioHealth CorpNASDAQ:DRIONASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE0.7890
- TODAY'S CHANGE (%)0.0688 (9.5529%)
- Bid / Lots0.7650/ 2
- Ask / Lots0.7898/ 10
- Open / Previous Close0.7500 / 0.7202
- Day Range
- 52 Week Range
- Volume68,069
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | DRIO |
|---|---|---|
| 09:32 ET | 2057 | 0.75 |
| 09:33 ET | 3761 | 0.75175 |
| 09:37 ET | 1057 | 0.7685 |
| 09:39 ET | 1000 | 0.7669 |
| 09:42 ET | 8041 | 0.7451 |
| 09:46 ET | 600 | 0.7669 |
| 09:50 ET | 100 | 0.764 |
| 09:51 ET | 130 | 0.75475 |
| 09:55 ET | 100 | 0.764 |
| 09:57 ET | 3739 | 0.76 |
| 10:02 ET | 100 | 0.7699 |
| 10:09 ET | 9639 | 0.77 |
| 10:11 ET | 4000 | 0.77 |
| 10:15 ET | 200 | 0.78 |
| 10:18 ET | 3299 | 0.7799 |
| 10:22 ET | 100 | 0.79 |
| 10:24 ET | 5600 | 0.8 |
| 10:26 ET | 900 | 0.7902 |
| 10:27 ET | 100 | 0.8 |
| 10:29 ET | 3200 | 0.7902 |
| 10:31 ET | 3413 | 0.795 |
| 10:36 ET | 200 | 0.795 |
| 10:42 ET | 200 | 0.7795 |
| 10:44 ET | 200 | 0.78 |
| 10:49 ET | 275 | 0.782101 |
| 10:51 ET | 100 | 0.79 |
| 10:56 ET | 2100 | 0.795 |
| 11:00 ET | 600 | 0.7825 |
| 11:02 ET | 100 | 0.795 |
| 11:03 ET | 2396 | 0.784288 |
| 11:05 ET | 200 | 0.7825 |
| 11:12 ET | 100 | 0.77 |
| 11:14 ET | 300 | 0.795 |
| 11:16 ET | 100 | 0.76 |
| 11:20 ET | 100 | 0.795 |
| 11:25 ET | 100 | 0.795 |
| 11:27 ET | 100 | 0.795 |
| 11:32 ET | 200 | 0.76 |
| 11:36 ET | 100 | 0.799 |
| 11:52 ET | 241 | 0.8 |
| 11:57 ET | 700 | 0.8 |
| 11:59 ET | 100 | 0.8 |
| 12:03 ET | 4500 | 0.7611 |
| 12:08 ET | 100 | 0.8 |
| 12:15 ET | 100 | 0.798 |
| 12:17 ET | 100 | 0.798 |
| 12:21 ET | 100 | 0.798 |
| 12:30 ET | 268 | 0.798 |
| 12:37 ET | 400 | 0.78 |
| 12:42 ET | 100 | 0.78 |
| 12:51 ET | 100 | 0.789 |
| 12:53 ET | 100 | 0.789 |
| 12:55 ET | 100 | 0.789 |
| 12:57 ET | 220 | 0.7849 |
| 01:00 ET | 300 | 0.789 |
Nov 21, 2024
Dario Signs Four New Employer Contracts Across Full Product Suite, from 8:30AM ET on Thursday Nov 21, 2024 by Dow Jones
8:30AM ET on Thursday Nov 21, 2024 by Dow Jones
Nov 7, 2024
Press Release: DarioHealth Reports Third Quarter 2024 Financial and Operating Results, from 6:30AM ET on Thursday Nov 07, 2024 by Dow Jones
6:30AM ET on Thursday Nov 07, 2024 by Dow JonesDarioHealth Reports Third Quarter 2024 Financial and Operating Results, from 6:30AM ET on Thursday Nov 07, 2024 by Dow Jones
6:30AM ET on Thursday Nov 07, 2024 by Dow Jones
Nov 4, 2024
Dario Expands Pharma Collaborations with Global Pharma Leader to Enhance User Engagement, from 8:30AM ET on Monday Nov 04, 2024 by Dow Jones
8:30AM ET on Monday Nov 04, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
DarioHealth Corp | 24.6M | -0.6x | --- |
Precision Optics Corporation Inc | 31.9M | -7.8x | --- |
Lifeward Ltd | 18.5M | -0.9x | --- |
Vivos Therapeutics Inc | 16.4M | -0.6x | --- |
Femasys Inc | 23.8M | -1.4x | --- |
Fuse Medical Inc | 5.9M | 2.2x | +2.06% |
Company Information
DarioHealth Corp. is a global digital therapeutics (DTx) company. The Company operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and highly engaging digital therapeutic interventions. Its platform and suite of solutions delivers personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. Its products include Dario Blood Pressure Monitoring System and Dario Blood Glucose Monitoring Starter Kit. Dario Blood Glucose Monitoring Starter Kit is a pocket-sized smartphone glucometer that manages diabetes in one ultra-compact device. Dario Blood Pressure Monitoring System is a blood pressure monitoring system used to measure blood pressure, which allows to store all its user readings in the Dario App. Its Dario mobile app is a complete, cloud-based solution for personal chronic condition management.
Contact Information
- Headquarters
- 322 W 57Th St. #33BNEW YORK, NY, United States 10019
- Phone
- 646-665-4667
- Fax
- 845-818-3588
Executives
- Independent Chairman of the Board
- Yoav Shaked
- Chief Executive Officer, Director
- Erez Raphael
- Chief Financial Officer, Treasurer, Secretary
- Zvi Ben-David
- Chief Operating Officer
- Tomer Ben-Kiki
- Chief Commercial Officer
- Steven Nelson
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $24.6M |
|---|---|
Revenue (TTM) | $23.1M |
Shares Outstanding | 34.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.45 |
EPS | $-1.29 |
Book Value | $2.14 |
P/E Ratio | -0.6x |
Price/Sales (TTM) | 1.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -278.12% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
